Literature DB >> 849559

Typhoid outbreak in Kingston, Ont: experience with high-dose oral ampicillin.

G Hardy, C J Padfield, P Chadwick, M W Partington.   

Abstract

Twenty-four children contracted typhoid fever at a summer camp near Kingston, Ont. Six were treated with chloramphenicol alone and 15 with high doses of ampicillin (300 mg/kg-d) by mouth. Ampicillin in this dosage was well tolerated except in three children in whom severe urticarial rashes developed and two who had significant diarrhea. However, high-dose oral ampicillin therapy had no advantage over that with lower doses or over chloramphenicol as judged by the rate of defervescence after the start of treatment, the rate of clinical relapse and the frequency of excretion of Salmonella typhi during convalescence.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 849559      PMCID: PMC1879449     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  6 in total

1.  Typhoid fever in children.

Authors:  A R Colon; D R Gross; M A Tamer
Journal:  Pediatrics       Date:  1975-10       Impact factor: 7.124

Review 2.  Typhoid fever in African and Indian children in Durban.

Authors:  J Scragg; C Rubidge; H L Wallace
Journal:  Arch Dis Child       Date:  1969-02       Impact factor: 3.791

3.  Typhoid at sea: epidemic aboard an ocean liner.

Authors:  J W Davies; W R Simon; E J Bowmer; A Mallory; K G Cox
Journal:  Can Med Assoc J       Date:  1972-04-22       Impact factor: 8.262

4.  Typhoid fever in children.

Authors:  A J Del Rosario; R E Haynes; H G Cramblett
Journal:  Ohio State Med J       Date:  1971-06

5.  Treatment of Salmonella typhi carriers with intravenous ampicillin.

Authors:  C Scioli; F Fiorentino; G Sasso
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

6.  Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever.

Authors:  R H Gilman; M Terminel; M M Levine; P Hernandez-Mendoza; R B Hornick
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.